Therapeutic Asset Ratings

13,248 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
TIL EGFR-TKI-resistant Non-Small Cell Lung Cancer	Tianjin Medical University General Hospital	P1	CCC (53)
(+)-VINCRISTINE Advanced Pancreatic Carcinoma	OHSU Knight Cancer Institute	P1	CCC (53)
[14c] lpm3770164 Huntington Disease	Luye Pharma Group Ltd.	P1	CCC (52)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1) Relapsed or Refractory Lymphoma	Hutchmed	P1	CCC (52)
allogeneic natural killer (NK) cells isolated from peripheral blood leukapheresis of individual donors. The cells are co-cultured in media containing interleukin 15 (IL-15) and nicotinamide (NAM, niacinamide) with expansion enhanced by the presence of feeder cells. The final cell population consists of 97-99% CD3-CD56+ NK cells, with >10% expressing CD16 (also known as Fc?RIII) and CD62L (also known as L-selectin) and with capacity to degranulate (surface expression of CD107? [Lysosome-associated membrane glycoprotein 1]; >10%), and to kill target cells (>10%) in co-culture assays against human cancer cell lines. Chronic Myeloid Leukemia	David Wald	P1	CCC (52)
AMISULPRIDE Major Depressive Disorder (MDD)	Simone Grimm	P1	CCC (52)
asc47 Chronic Weight Management	Ascletis Pharma (China) Co., Limited	P1	CCC (52)
AZD1775 Advanced Solid Tumours	AstraZeneca	P1	CCC (52)
azd2389 Advanced Chronic Liver Disease	AstraZeneca	P1	CCC (52)
Bortezomib Carcinoma Breast Stage IV	Andrew Hantel, MD	P1	CCC (52)
cd19-ucart Acute Lymphoblastic Leukemia, Adult B-Cell	The General Hospital of Western Theater Command	P1	CCC (52)
cd22 car-transduced t cells NHL	Tongji Hospital	P1	CCC (52)
Cediranib Invasive Breast Carcinoma	Jonsson Comprehensive Cancer Center	P1	CCC (52)
Cediranib Pancreatic Cancer	City of Hope Medical Center	P1	CCC (52)
Cediranib Recurrent Lung Carcinoma	National Cancer Institute (NCI)	P1	CCC (52)
Cediranib Recurrent Lymphoepithelioma of the Nasopharynx	Fox Chase Cancer Center	P1	CCC (52)
DYNAMOS Overweight	Beijing QL Biopharmaceutical Co.,Ltd	P1	CCC (52)
Empagliflozin Sodium-Glucose Transporter 2 Inhibitors	Stanford University	P1	CCC (52)
Eribulin Advanced Ovarian Carcinoma	OHSU Knight Cancer Institute	P1	CCC (52)
Etavopivat Healthy Volunteers	Novo Nordisk A/S	P1	CCC (52)
Etavopivat Healthy Volunteers Sickle Cell Disease, Thalassemia	Novo Nordisk A/S	P1	CCC (52)
Irinotecan Esophagogastric Cancer	AbbVie	P1	CCC (52)
Itraconazole Healthy Volunteers	Bayer	P1	CCC (52)
Levonorgestrel Healthy Volunteers (Non-alcoholic Steatohepatitis)	Novo Nordisk A/S	P1	CCC (52)
Losartan Locally Advanced Pancreatic Ductal Adenocarcinoma	Fox Chase Cancer Center	P1	CCC (52)

Showing 51 to 75 of 13,248 assets

PreviousPage 3 of 530Next